{
    "clinical_study": {
        "@rank": "65432", 
        "arm_group": [
            {
                "arm_group_label": "Piracetam", 
                "arm_group_type": "Active Comparator", 
                "description": "2 g intravenous piracetam"
            }, 
            {
                "arm_group_label": "Dimenhydrinate", 
                "arm_group_type": "Active Comparator", 
                "description": "Dimenhydrinate 100 mg intravenous"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to investigate efficacy of two different intravenous drugs (dimenhydrinate\n      and piracetam) in the symptomatic management of peripheral vertigo.\n\n      The patients will be randomized in two groups according to symptomatic treatment modalities:\n      Dimenhydrinate (100 mg) and piracetam (2 g) will be given in 100 cc normal saline in 30\n      minutes. Each patient will be asked if her/his vertigo symptoms resolved or not, according\n      to a numeric rating scale (0=no vertigo, 10=worst possible vertigo). The patient will be\n      rate the intensity of symptoms in the following times:\n\n        -  Numeric rating scale (1 to 10): Admission\n\n        -  Numeric rating scale (1 to 10): After the study drug (No ambulation)*\n\n        -  Numeric rating scale (1 to 10): After the study drug (Ambulation)*\n\n             -  Ambulation refers to head movements or walking in the room, if applicable."
        }, 
        "brief_title": "Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Peripheral Vertigo", 
        "condition_browse": {
            "mesh_term": [
                "Vertigo", 
                "Dizziness"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presenting to emergency department with vertigo symptoms\n\n          -  Adult patients (over 18)\n\n          -  Agree to participate to study (understanding the study protocol and signing the\n             informed consent form)\n\n        Exclusion Criteria:\n\n          -  Patients under 18 years\n\n          -  Patients diagnosed with ischemic/hemorrhagic stroke after neuroimaging\n\n          -  Patient diagnosed with transient ischemic attack\n\n          -  Pregnants\n\n          -  Patients taking any analgesics or antihistaminic drugs last 24 hours\n\n          -  Documented or declared allergy to dimenhydrinate, piracetam or benzodiazepines\n\n          -  Patients who do not agree to participate to the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "94", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890538", 
            "org_study_id": "KOU KAEK 2013/174"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dimenhydrinate", 
                "intervention_name": "Administration of 100 mg dimenhydrinate intravenous", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Piracetam", 
                "intervention_name": "2 g piracetam intravenous", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dimenhydrinate", 
                "Piracetam"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "vertigo", 
            "dimenhydrinate", 
            "piracetam"
        ], 
        "lastchanged_date": "May 2, 2014", 
        "link": {
            "url": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11020677"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Kocaeli", 
                    "country": "Turkey", 
                    "zip": "41000"
                }, 
                "name": "Kocaeli University"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial", 
        "overall_official": {
            "affiliation": "Kocaeli University", 
            "last_name": "Nurettin \u00d6zg\u00fcr Do\u011fan, M.D., Assistant Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in numeric rating scale", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline in numeric rating scale at 30th minute"
        }, 
        "reference": {
            "PMID": "15262457", 
            "citation": "Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther. 2004 Jun;26(6):866-77."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890538"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kocaeli University", 
            "investigator_full_name": "Nurettin \u00d6zg\u00fcr Do\u011fan", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Kocaeli University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kocaeli University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}